Drugdiscovery >> Drug Development >> News
3365
Views
Daiichi Sankyo and Agendia will work togetheron oncology research - drugdiscovery.com
Daiichi Sankyo and Agendia will work togetheron oncology research - drugdiscovery.com


Agendia and Daiichi Sankyo today announced that they signed an agreement on further oncology drug development researches. Agendia is going to share its biomarker research with Daiichi, which is going to give in its clinical trial results.
Read More >>


Tags: Daiichi Sankyo, Agendia, drug development, clinical trials, biomarker research, oncology - April 24, 2014
Related Articles
3105
Views
A way to personalized oncology treatments A way to personalized oncology treatments
Every cancer is different - say scientists. According to the newest studies, patient pre-profiling and personalized tumor treatment is the future. Read More >>

Tags: tumor, oncology, drug,

3632
Views
Research and Markets: PharmaPoint: Crohn's Disease - Current and Future Players Research and Markets: PharmaPoint: Crohn's Disease - Current and Future Players
Current and Future Players. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Crohn's Disease Market. The report identifies and anal Read More >>

Tags: chrone disease, pharmaceutical research

3103
Views
New oncology drug of Pfizer has fallen at late stage trials New oncology drug of Pfizer has fallen at late stage trials
Dacomitinib, the newly developed cancer drug of Pfizer has fallen to produce long-term effect. As it was announced, the new drug did not produce a long term survival rate incrision. Read More >>

Tags: cancer, pfizer, drug, Phase I trial

2774
Views
Breakthrough in cancer research – Rational, personalized combination therapy against cancer driver genes Breakthrough in cancer research – Rational, personalized combination therapy against cancer driver genes
There is a breakthrough now in cancer research and therapy providing personalized targeted drug combinations for cancer patients to treat the disease and overcome primary and secondary resistance due Read More >>

Tags: cancer drugs, cancer research, DriverHit Library, drug development, genes

3255
Views
Scripps Florida Scientists has a new research towards a better diabetes drug Scripps Florida Scientists has a new research towards a better diabetes drug
The Scripps Research institute has a new foundings in the field of common diabetes drugs. Ths surprising research result are hoped to lead scientist towards a more effecite treatment for high blood su Read More >>

Tags: diabetes, diabetes drug, the scripps research institute, scripps diabetes, drug development, diabetic

1396
Views
Translational Research Still Faces Financial Problems Translational Research Still Faces Financial Problems
State of Translational Research 2013 is the first survey which focuses on this type of drug discovery. The data have some very important consequences. Expert think that more flexible way of thinking a Read More >>

Tags: collaboration, institue, finance

3982
Views
Financial risks of Drug Development Financial risks of Drug Development
Low budget in drug development is, of course, just the tip of an iceberg when it comet to drug research. However, today's pharmaceutical companies have to be prepared for financial stress, which leads Read More >>

Tags: companies, research, company, finance

2680
Views
Giant investment in T-cell research Giant investment in T-cell research
T-cells are considered to be among the greatest inventions of the year. Juno Therapeutics now invested a large sum into an A round, the biggest one which was ever processed. Read More >>

Tags: process, A round, Juno, T-cell

1262
Views
New heights of meningitis research New heights of meningitis research
Latest meningitis researches are focusing on T-cells of the brain. When scientists will be able to find out how this virus breaks through the borders of the immune system, it is going to be easy to fi Read More >>

Tags: meningitis, immune system, T cell

3745
Views
New hope in curing gialoblastoma New hope in curing gialoblastoma
Scientist examined gialoblastoma and found some inactivated cells which would destroy the tumour-cells. Tests on mice sohw, that if these cells are reactivated, the patients can live 2-3 times longer. Read More >>

Tags: gialoblastoma, brain cancer, research

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013